Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis.
- Published In:
- Journal of hepatology, 81(5), 837-846 (2024)
- Authors:
- Lawitz, Eric J, Fraessdorf, Mandy, Neff, Guy W, Schattenberg, Jörn M, Noureddin, Mazen, Alkhouri, Naim, Schmid, Bernhard, Andrews, Charles P, Takács, István, Hussain, Samina Ajaz, Fenske, Wiebke K, Gane, Edward J, Hosseini-Tabatabaei, Azadeh, Sanyal, Arun J, Mazo, Daniel F, Younes, Ramy
- Database ID:
- RPEP-08634
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08634APA
Lawitz, Eric J; Fraessdorf, Mandy; Neff, Guy W; Schattenberg, Jörn M; Noureddin, Mazen; Alkhouri, Naim; Schmid, Bernhard; Andrews, Charles P; Takács, István; Hussain, Samina Ajaz; Fenske, Wiebke K; Gane, Edward J; Hosseini-Tabatabaei, Azadeh; Sanyal, Arun J; Mazo, Daniel F; Younes, Ramy. (2024). Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis.. Journal of hepatology, 81(5), 837-846. https://doi.org/10.1016/j.jhep.2024.06.003
MLA
Lawitz, Eric J, et al. "Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis.." Journal of hepatology, 2024. https://doi.org/10.1016/j.jhep.2024.06.003
RethinkPeptides
RethinkPeptides Research Database. "Efficacy, tolerability and pharmacokinetics of survodutide, ..." RPEP-08634. Retrieved from https://rethinkpeptides.com/research/lawitz-2024-efficacy-tolerability-and-pharmacokinetics
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.